Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vistagen Therapeutics (VTGN) Other Operating Expenses (2020 - 2024)

Vistagen Therapeutics (VTGN) has disclosed Other Operating Expenses for 2 consecutive years, with $4.1 million as the latest value for Q1 2024.

  • Quarterly Other Operating Expenses changed N/A to $4.1 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $4.1 million through Dec 2024, changed N/A year-over-year, with the annual reading at $25700.0 for FY2021, N/A changed from the prior year.
  • Other Operating Expenses hit $4.1 million in Q1 2024 for Vistagen Therapeutics, up from $200.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $4.1 million in Q1 2024 to a low of $200.0 in Q2 2020.